Nordic Bone
ABOUT USINVESTORSPIPELINENEWSCAREERSCONTACT

November 10, 2008

Osteologix to Present Corporate Overview at Upcoming Conferences

Rodman and Renshaw Annual Global Investment Conference

BIO Europe 14th Annual International Partnering Conference

October 29, 2008

Osteologix to Present at 7th Annual BIO Investor Forum

Thursday October 30
Palace Hotel
San Francisco, CA

June 17, 2008

Osteologix to Present Corporate Overview and Phase 2 Osteoporosis Data at the BIO International Conference

2008 BIO International Convention

May 28, 2008

Osteologix to Present at the FBR Capital Markets 12th Annual Spring Investor Conference

May 27, 2008

Poster: Effect of 3 Doses of Strontium Malonate (NB S101) on Markers of Bone Turnover and Bone Mineral Density: The STRONG Study

May 27, 2008

Osteologix Presents Phase 2 Osteoporosis Data at a Major European Medical Conference

Journal Publication Highlights Bone Formation Activity of NB S101

May 15, 2008

Osteologix to Present at the Rodman and Renshaw 5th Annual Global Healthcare Conference

May 7, 2008

Osteologix IND for NB S101 for Osteoporosis Accepted by FDA

April 17, 2008

Osteologix Completes $5.3 Million Private Placement Financing

March 31, 2008

Osteologix Enters Into $5.3 Million Private Placement Financing Agreement

February 6, 2008

Osteologix to Present at BIO CEO & Investor Conference